We are pleased to announce that we now accept all major credit cards, as well as HSA and FSA for payment!
Vaginal dryness occurs when vaginal tissues do not have enough moisture or lubrication. It may cause burning, irritation, itching, tenderness, discomfort with everyday activity, or pain during sexual activity.
It is especially common during perimenopause and after menopause as estrogen levels change, but menopause is not the only possible cause. Breastfeeding, medications, cancer treatment, skin conditions, infections, and exposure to irritating products may also contribute.
Vaginal dryness treatment should therefore reflect the cause, severity, and symptoms affecting each patient.
Options may include vaginal moisturizers, lubricants, low-dose vaginal estrogen, other prescription medication, pelvic-floor care, or systemic menopause hormone therapy when symptoms extend beyond the vaginal area.
Optimal Female Wellness helps patients understand what may be contributing to discomfort and explore an individualized treatment plan based on health history, menopause status, symptoms, medications, and preferences.
Dryness is sometimes discussed only in relation to sex, but symptoms can affect daily comfort as well.
Women may notice:
ACOG notes that declining estrogen may affect both the vagina and the vulva, meaning irritation can sometimes be noticeable even when a woman is not sexually active.
Persistent symptoms deserve attention rather than being accepted as an unavoidable part of aging.
Vaginal dryness does not necessarily begin after the final menstrual period.
Estrogen production can become less predictable during perimenopause, and vaginal or vulvar symptoms may appear while periods are still occurring.
Possible early changes include:
Symptoms may become more persistent as estrogen levels decline further.
Someone does not need to wait until menopause is complete before discussing treatment.
Lower estrogen levels during breastfeeding may temporarily contribute to dryness.
ACOG notes that vaginal dryness after pregnancy is especially common while breastfeeding and may be treated with lubricants or local estrogen therapy when appropriate.
Postpartum symptoms may also involve:
Pain after childbirth should therefore not always be assumed to be caused only by vaginal dryness.
Evaluation begins with understanding the pattern.
A clinician may ask:
A pelvic examination may be recommended when symptoms persist or when another condition needs to be ruled out.
The examination may evaluate:
Estrogen decline affects urinary tissues as well as vaginal tissue.
GSM may include:
ACOG includes frequent urinary infections and urinary frequency among recognized GSM symptoms.
However, burning or urinary urgency should not automatically be assumed to be menopause-related.
Urinalysis or additional evaluation may be appropriate when an active infection is possible.
Improvement is not necessarily immediate.
ACOG notes that topical estrogen often begins improving dryness or painful intercourse within a few weeks, although the response varies from person to person. (acog.org)
Tissue changes develop gradually.
Patients may still use lubricant during sexual activity while treatment takes effect.
If symptoms do not improve, the diagnosis should be reconsidered rather than simply increasing treatment without evaluation.
Pain and desire are closely connected.
Someone who expects intimacy to hurt may naturally become less interested in sexual activity.
In this situation, low libido may be a response to discomfort rather than a primary desire disorder.
Treating dryness, irritation, or pelvic-floor pain may improve sexual well-being without requiring a libido medication or testosterone therapy.
Sexual-health treatment should therefore ask whether intimacy is comfortable before assuming the primary problem is lack of desire.
Dry or fragile vaginal tissue can sometimes bleed after penetration because the tissue is thinner and more easily irritated.
However, bleeding should not automatically be blamed on dryness.
Evaluation is particularly important for:
Bleeding can have several causes involving the cervix, vagina, uterus, medications, infection, or other conditions.
Postmenopausal bleeding should always be medically evaluated.
Dryness alone generally does not cause strong vaginal odor or unusual discharge.
Symptoms that may warrant testing for infection include:
Yeast infections, bacterial vaginosis, and sexually transmitted infections may overlap with symptoms of GSM.
The presence of menopause does not rule out infection.
Custom-compounded vaginal hormones may be promoted as more individualized or more natural.
However, compounded products do not undergo the same FDA premarket review for safety, effectiveness, manufacturing quality, and dosing consistency as FDA-approved medications.
Many FDA-approved products already provide low-dose estradiol or other established vaginal treatments.
The decision to use a compounded product should involve a clear medical reason rather than the assumption that compounded means safer.
Energy-based vaginal devices have been marketed for menopause-related dryness and sexual symptoms.
Patients should understand that these procedures are different from established medication treatments.
Evidence regarding effectiveness and long-term safety continues to be evaluated, and patients should ask:
A treatment being marketed as “nonhormonal” does not automatically mean it has stronger evidence or fewer risks.
The vagina does not need to be cleansed internally.
Douching and heavily scented products may disrupt normal vaginal conditions or irritate sensitive tissue.
Potential irritants include:
When vulvar tissue has become more sensitive during menopause, products that were previously tolerated may start causing discomfort.
Gentle external cleansing is generally preferable to aggressive cleansing or fragranced products.
Vaginal dryness is common during perimenopause and menopause, but it does not need to be accepted as an unavoidable part of aging.
The best treatment depends on whether symptoms come from menopause-related tissue changes, medication effects, breastfeeding, infection, pelvic-floor dysfunction, irritation, or another condition.
Optimal Female Wellness provides individualized evaluation and treatment support for vaginal dryness and other menopause-related concerns.
Schedule an appointment to discuss your symptoms, medications, menopause history, sexual comfort, urinary concerns, and whether moisturizers, lubricants, vaginal estrogen, another prescription treatment, or referral may be appropriate.
Declining estrogen during perimenopause and menopause is a common cause. Breastfeeding, medications, cancer treatment, irritation, infections, and certain medical conditions may also contribute.
The best treatment depends on the cause and severity. Options may include vaginal moisturizers, lubricants, low-dose vaginal estrogen, prasterone, ospemifene, pelvic-floor therapy, or systemic hormone therapy when other menopause symptoms are also present.
A vaginal moisturizer is used routinely to support moisture and everyday comfort. A lubricant is used during sexual activity to reduce friction.
Yes. Declining estrogen can cause dryness, burning, itching, and irritation as part of genitourinary syndrome of menopause. Infections and vulvar skin conditions can cause similar symptoms.
Yes. Low-dose vaginal estrogen can help restore vaginal tissue thickness and elasticity and reduce dryness and irritation in appropriately evaluated patients.
No. Vaginal estrogen delivers a low dose primarily to local tissues. Systemic hormone therapy circulates through the bloodstream and is used for symptoms affecting the whole body, such as hot flashes.
Yes. Reduced lubrication and thinner, less elastic vaginal tissue can make penetration painful. Pelvic-floor tension may also develop when pain continues.
Yes. GSM may include urinary urgency, frequency, burning, and recurrent urinary tract infections because lower estrogen also affects urinary tissues.
Seek evaluation when symptoms persist, affect daily life or intimacy, or occur with bleeding, sores, unusual discharge, odor, pelvic pain, or urinary concerns.
Not necessarily. Unlike some menopause symptoms, GSM often persists or becomes more noticeable without treatment. Ongoing treatment may be needed to maintain symptom relief.